Diseases [C] » Neoplasms [C04] » Neoplasms by Site
Description
A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc. MeSH
Hierarchy View
Subtype Terms (17)
Abdominal Neoplasms
24 drugs (21 approved, 3 experimental)
Bone Neoplasms
41 drugs (28 approved, 13 experimental)
Breast Neoplasms
1633 drugs (504 approved, 1129 experimental)
Digestive System Neoplasms
60 drugs (31 approved, 29 experimental)
Endocrine Gland Neoplasms
16 drugs (11 approved, 5 experimental)
Eye Neoplasms
6 drugs (4 approved, 2 experimental)
Head and Neck Neoplasms
503 drugs (203 approved, 300 experimental)
Hematologic Neoplasms
256 drugs (121 approved, 135 experimental)
Nervous System Neoplasms
4 drugs (2 approved, 2 experimental)
Pelvic Neoplasms
14 drugs (11 approved, 3 experimental)
Skin Neoplasms
131 drugs (76 approved, 55 experimental)
Soft Tissue Neoplasms
6 drugs (5 approved, 1 experimental)
Thoracic Neoplasms
36 drugs (25 approved, 11 experimental)
Urogenital Neoplasms
41 drugs (25 approved, 16 experimental)
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (16)
Phase 2 Indicated Drugs (16)
Phase 1 Indicated Drugs (8)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (17)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
